Does the European Respiratory Society (ERS) recommend sputum fungal culture for bronchiectasis etiologic workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does ERS Recommend Sputum Fungal Culture for Bronchiectasis Etiologic Workup?

No, the European Respiratory Society (ERS) does not include sputum fungal culture in the minimum bundle of etiological tests for bronchiectasis. The 2017 ERS guidelines specifically recommend only three core tests: differential blood count, serum immunoglobulins (IgG, IgA, IgM), and testing for allergic bronchopulmonary aspergillosis (ABPA), with sputum culture mentioned only for bacterial monitoring purposes 1.

ERS Minimum Etiological Testing Bundle

The ERS guidelines explicitly state the minimum bundle as a conditional recommendation with very low quality evidence 1:

  • Differential blood count - to identify lymphopenia, neutropenia suggesting immune deficiency, or lymphocytosis suggesting haematological malignancy 1
  • Serum immunoglobulins (total IgG, IgA, IgM) - to detect common variable immune deficiency, present in 2-8% of bronchiectasis patients, which is modifiable with immunoglobulin replacement 1
  • Testing for ABPA - because establishing this diagnosis alters management 1

Sputum Culture Recommendations

The ERS guidelines state that sputum culture is expected to be undertaken for monitoring purposes of bacterial infection, not as part of the etiological workup 1. The 2025 ERS guidelines similarly recommend initial diagnostic workup should include sputum culture for bacteria, mycobacteria, and fungi, but this appears in the context of comprehensive management rather than the minimum etiological bundle 2.

Mycobacterial culture is mentioned as potentially helpful only in selected cases where non-tuberculous mycobacteria (NTM) are suspected as an aetiological cause 1.

Clinical Context for Fungal Testing

Fungal culture becomes relevant in specific clinical scenarios rather than routine etiological workup:

  • When ABPA is suspected based on screening tests (which is part of the minimum bundle) 1
  • When clinical features suggest fungal disease 1
  • In patients with severe or rapidly progressive disease where additional tests beyond the minimum bundle are appropriate 1

Research demonstrates that ITS2 sequencing greatly increases detection of fungi from sputum compared to culture, with different fungal profiles in CF versus non-CF bronchiectasis 3. However, this research finding has not translated into guideline recommendations for routine fungal culture in etiological workup.

Important Caveats

The ERS acknowledges that no publications directly addressed whether routine aetiological investigation protocols provide benefit compared to clinically driven investigations 1. The recommendation for the minimum bundle is based on very low quality evidence, with only observational studies showing that 7-37% of patients had management changes following aetiological investigation 1.

Additional tests beyond the minimum bundle may be appropriate when specific clinical features suggest particular etiologies, but fungal culture is not part of the standardized initial etiological workup 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Bronchiectasis in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.